WO2024160988 - FERMENTATION PRODUCT FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH METABOLIC SYNDROME AND HEPATIC STEATOSIS
National phase entry is expected:
Publication Number
WO/2024/160988
Publication Date
08.08.2024
International Application No.
PCT/EP2024/052559
International Filing Date
01.02.2024
Title **
[English]
FERMENTATION PRODUCT FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH METABOLIC SYNDROME AND HEPATIC STEATOSIS
[French]
PRODUIT DE FERMENTATION DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE MALADIES ASSOCIÉES AU SYNDROME MÉTABOLIQUE ET À LA STÉATOSE HÉPATIQUE
Applicants **
ALFASIGMA S.P.A.
Via Ragazzi del '99 n.5
40133 Bologna, IT
Inventors
VESCI, Loredana
c/o ALFASIGMA S.p.A.
Via Pontina, Km 30, 400
00071 Pomezia (RM), IT
GIANNINI, Giuseppe
c/o ALFASIGMA S.p.A.
Via Pontina, Km 30,400
00071 Pomezia (RM), IT
GIORGI, Fabrizio
c/o ALFASIGMA S.p.A.
Via Pontina, Km 30, 400
00071 Pomezia (RM), IT
Priority Data
102023000001434
01.02.2023
IT
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1229 | |
| EPO | Filing, Examination | 5322 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3310 |
Total: 11033 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present inven on relates to a bacterial strain, Lac plan bacillus plantarum DSM 33683, and to a composi on comprising the fermenta on product of this bacterial strain, obtained in the presence of at least one plant extract. The composi on is useful in the treatment and/or preven on of diseases associated with metabolic syndrome or in the treatment and/or preven on of insulin resistance syndrome and in the treatment and/or preven on of hepa c steatosis. It also relates to the process for obtaining the fermenta on product and the composi on comprising the same.[French]
La présente invention concerne une souche bactérienne, Lactiplantibacillus plantarum DSM 33683, et une composition contenant le produit de fermentation de cette souche bactérienne, obtenue en présence d'au moins un extrait végétal. La composition est utile dans le traitement et/ou la prévention de maladies associées au syndrome métabolique ou dans le traitement et/ou la prévention du syndrome de résistance à l'insuline et dans le traitement et/ou la prévention de la stéatose hépatique. L'invention concerne également le procédé d'obtention du produit de fermentation et la composition le contenant.